HOME >> MEDICINE >> NEWS
Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia

CHICAGO - An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.

"Patients taking dasatinib achieve complete cytogenetic response - absence of the mutated protein that drives this disease - more rapidly than we've observed historically using the current front-line therapy. Side effects are very manageable," says Ehab L. Atallah, M.D., lead author of the study and a fellow in M. D. Anderson's Department of Leukemia. Atallah presented study results at the annual meeting of the American Society of Clinical Oncology in Chicago Saturday June 2nd, 2007. The clinical trial remains in progress with 35 patients enrolled.

Dasatinib, known commercially as Sprycel and produced by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration a year ago for use by patients whose disease is unresponsive to or becomes resistant to the front-line therapy imatinib. Both drugs bind to and block a genetically flawed protein known as BCR-ABL, which causes the disease. Atallah explains that dasatinib binds to both forms BCR-ABL while imatinib blocks only one.

"Our hypothesis is that treating with dasatinib first will produce an earlier response, which may translate to a better overall survival," Atallah says. "We haven't proved that here, but these early results are encouraging."

Atallah and colleagues evaluated 35 patients who enrolled in the clinical trial between November 2005 and December 2006. Patients receive either 100 mg of dasatinib once daily or 50 mg twice daily.

Thirty four patients had been on the clinical trial for at least three months when Atallah and lead researcher Jorge Cortes, M.D., professor in the Department of Leukemia, evaluated their data. They found that 77 percent of pati
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
2-Jun-2007


Page: 1 2

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Most seniors now have drug coverage, U-M study shows
3. Wireless technology shows promise in diagnosing pediatric intestinal disease
4. Study shows radiofrequency ablation highly effective in treating kidney tumors
5. Method shows promise for early detection of pancreatic cancer
6. Organic farming can feed the world, U-M study shows
7. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
8. Borderline personality disorder shows improvements with intensive psychotherapy
9. New drug shows promise in treatment of advanced thyroid cancer
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2020)... ... June 04, 2020 , ... ... announced today that its client, PrivaPath Diagnostics, Inc. (also known as LetsGetChecked), ... Coronavirus (COVID-19) Test, a convenient, at-home diagnostic test kit for detection of ...
(Date:6/2/2020)... ... June 02, 2020 , ... RemetricHealth ... been serving the healthcare industry for more than a decade, announced today the ... care offerings. , In 2010, RemetricHealth, then known as PMD Healthcare, developed the ...
(Date:5/30/2020)... ... May 30, 2020 , ... ... virtual solutions that can meet the needs of a COVID-riddled world, while shaping ... solutions abide by the necessary compliances and augment the caregiving standards through ...
(Date:5/27/2020)... ... , ... The podiatrists and foot doctors of Advanced Foot & Ankle Specialists ... Ann Arbor Michigan. Dr. Tomasz Biernacki states that “Podiatrists can help support ... hospital. We have been seeing patients in the hospital for the past 3 months, ...
(Date:5/26/2020)... ... ... Today TRC Companies (“ TRC ”) announced the release of its ... and leaders assess whether their organizations are prepared to move forward as the country ... to assist business leaders evaluate their readiness relative to CDC guidance and provides ideas ...
Breaking Medicine News(10 mins):
(Date:5/30/2020)... ... May 30, 2020 , ... During a crisis, the platitude “stay strong” ... - it is developed and strengthened through hardship. Recent research conducted by PsychTests.com ... in certain practices in order to stay strong in the face of adversity. It ...
(Date:5/28/2020)... ... , ... When Sean Fitzgerald was in business leadership for a national in-home ... physical care services needed to keep older adults in their homes, but it was ... pleased to be in a position to help provide those property maintenance and repair ...
(Date:5/28/2020)... ... May 28, 2020 , ... May is Talking is Power Month, ... champions who care about them. The focus of Power to Decide’s #TalkingIsPower campaign reminds ... young people. Power to Decide’s Mackenzie Piper, MPH, CHES, provides five strategies parents, trusted ...
Breaking Medicine Technology:
Cached News: